Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Walgreens Boots Alliance (WBA)
NASDAQ:WBA
Holding WBA?
Track your performance easily
WBA Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$8.08 - $25.63
Previous Close$9.67
Volume20.45M
Average Volume (3M)23.58M
Market Cap
$8.18B
Enterprise Value$39.66B
Total Cash (Recent Filing)$3.11B
Total Debt (Recent Filing)$32.85B
Price to Earnings (P/E)―
Beta0.84
Next Earnings
Jan 10, 2025EPS Estimate
$0.38Last Dividend Ex-Date
Nov 18, 2024Dividend Yield10.56%
Share Statistics
EPS (TTM)-10.01
Shares Outstanding864,617,130
10 Day Avg. Volume14,304,932
30 Day Avg. Volume23,583,937
Standard Deviation0.10
R-Squared0.11
Alpha-0.03
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.78
Price to Sales (P/S)0.06
Price to Cash Flow (P/CF)1.50
P/FCF Ratio1.40
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.27
Enterprise Value/Gross Profit1.50
Enterprise Value/Ebitda-3.46
Forecast
1Y Price Target
$9.79Price Target Upside1.24% Upside
Rating ConsensusHold
Number of Analyst Covering13
Walgreens Boots Alliance News
Bulls Say, Bears Say
Bulls Say
Financial PerformanceWalgreens Boots Alliance reported better than expected earnings per share, exceeding consensus estimates.
Management And StrategyAn upgraded management team is executing against an achievable bar from trough results and a valuation that appears to more than incorporate the uncertainty of the current situation.
Strategic InitiativesThe company continues to execute on its transformational consumer-centric healthcare strategy, aiming to provide a better experience for customers, improve outcomes and lower overall healthcare costs.
Bears Say
Cash Flow And DebtThe company does not currently generate any cash flow and faces significant debt challenges, particularly with upcoming debt obligations.
Earnings And Operating ResultsChallenged operating results are expected to persist, with ongoing pressure on the US Retail business and US Healthcare.
ProfitabilityA step-down in profitability is expected, largely due to the reduction of sale-leasebacks, COR equity method income, and higher tax rates.
---
Ownership Overview
17.72% Insiders
13.08% Mutual Funds
0.01% Other Institutional Investors
42.37% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
The estimated number of people who visited one or more of the websites owned by Walgreens Boots Alliance
Desktop Users
Mobile Users
WBA FAQ
What was Walgreens Boots Alliance’s price range in the past 12 months?
Walgreens Boots Alliance lowest stock price was $8.08 and its highest was $25.63 in the past 12 months.
What is Walgreens Boots Alliance’s market cap?
Currently, no data Available
When is Walgreens Boots Alliance’s upcoming earnings report date?
Walgreens Boots Alliance’s upcoming earnings report date is Jan 10, 2025 which is yesterday.
How were Walgreens Boots Alliance’s earnings last quarter?
Walgreens Boots Alliance released its earnings results on Oct 15, 2024. The company reported $0.39 earnings per share for the quarter, beating the consensus estimate of $0.358 by $0.032.
Is Walgreens Boots Alliance overvalued?
According to Wall Street analysts Walgreens Boots Alliance’s price is currently Undervalued.
Does Walgreens Boots Alliance pay dividends?
Walgreens Boots Alliance pays a Quarterly dividend of $0.25 which represents an annual dividend yield of 10.56%. See more information on Walgreens Boots Alliance dividends here
What is Walgreens Boots Alliance’s EPS estimate?
Walgreens Boots Alliance’s EPS estimate is $0.38.
How many shares outstanding does Walgreens Boots Alliance have?
Walgreens Boots Alliance has 863,487,700 shares outstanding.
What happened to Walgreens Boots Alliance’s price movement after its last earnings report?
Walgreens Boots Alliance reported an EPS of $0.39 in its last earnings report, beating expectations of $0.358. Following the earnings report the stock price went up 15.808%.
Which hedge fund is a major shareholder of Walgreens Boots Alliance?
Among the largest hedge funds holding Walgreens Boots Alliance’s share is Gamco Investors, Inc. ET AL. It holds Walgreens Boots Alliance’s shares valued at 11M.
---
Walgreens Boots Alliance Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$9.79 (1.24% Upside)
$9.79 (1.24% Upside)
Blogger Sentiment
Neutral
WBA Sentiment 54%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 875.5K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.3%
Last 30 Days ▼ 1.3%
Last 30 Days ▼ 1.3%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-58.17%
12-Months-Change
Fundamentals
Return on Equity
-56.69%
Trailing 12-Months
Asset Growth
-16.13%
Trailing 12-Months
Company Description
Walgreens Boots Alliance
Retail pharmacy leader Walgreens Boots Alliance (NASDAQ:WBA) operates through its namesake brand Walgreens in the U.S. and Boots in the U.K. In addition, it owns retail and business brands including the No7 Beauty Company, Duane Reade, Ahumada in Chile, and Benavides in Mexico. The company also targets equity investments in healthcare, pharmacy, and retail and has a presence in over 25 countries with more than 450,000 employees.
---
WBA Company Deck
---
WBA Earnings Call
Q4 2024
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call reflects a mixed sentiment with notable achievements in cost reduction, positive cash flow, and growth in the International and U.S. Healthcare segments. However, these are offset by significant challenges, including a substantial EPS decline, U.S. Retail Pharmacy headwinds, and plans for extensive store closures. The company is focused on strategic initiatives to stabilize its operations and strengthen its balance sheet, but faces ongoing pressures from the consumer market and legal charges.Read More>---
WBA Revenue Breakdown
78.41% U.S. Retail Pharmacy
15.95% International
5.65% U.S. Healthcare
---
WBA Stock 12 Month Forecast
Average Price Target
$9.79
▲(1.24% Upside)
Technical Analysis
Best Analysts Covering WBA
1 Year
1 Year Success Rate
8/15 ratings generated profit
1 Year Average Return
-0.54%
reiterated a buy rating 5 days ago
Copying Lisa Gill's trades and holding each position for 1 Year would result in 53.33% of your transactions generating a profit, with an average return of -0.54% per trade.
---